Chih-Ming Su

552 total citations
25 papers, 404 citations indexed

About

Chih-Ming Su is a scholar working on Molecular Biology, Cancer Research and Oncology. According to data from OpenAlex, Chih-Ming Su has authored 25 papers receiving a total of 404 indexed citations (citations by other indexed papers that have themselves been cited), including 12 papers in Molecular Biology, 12 papers in Cancer Research and 10 papers in Oncology. Recurrent topics in Chih-Ming Su's work include Epigenetics and DNA Methylation (6 papers), Breast Cancer Treatment Studies (5 papers) and Cancer Cells and Metastasis (4 papers). Chih-Ming Su is often cited by papers focused on Epigenetics and DNA Methylation (6 papers), Breast Cancer Treatment Studies (5 papers) and Cancer Cells and Metastasis (4 papers). Chih-Ming Su collaborates with scholars based in Taiwan, United States and Greece. Chih-Ming Su's co-authors include Ka‐Wai Tam, Chih‐Hsiung Wu, Yuan‐Soon Ho, Tsai‐Wei Huang, Wei‐Hwa Lee, Alexander Wu, Chi‐Tai Yeh, Liang-Shun Wang, Yen‐Kuang Lin and Ruo-Kai Lin and has published in prestigious journals such as Cancer Research, Life Sciences and Annals of Surgical Oncology.

In The Last Decade

Chih-Ming Su

25 papers receiving 400 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Chih-Ming Su Taiwan 12 180 126 116 104 48 25 404
Qinghong Qin China 15 224 1.2× 123 1.0× 223 1.9× 156 1.5× 76 1.6× 25 560
Marilena Castelli Italy 14 229 1.3× 53 0.4× 88 0.8× 83 0.8× 16 0.3× 23 413
Susan Loftus United States 6 89 0.5× 214 1.7× 89 0.8× 147 1.4× 59 1.2× 10 579
Shotaro Umezawa Japan 8 226 1.3× 134 1.1× 77 0.7× 178 1.7× 39 0.8× 12 504
Lifang Wu China 14 189 1.1× 56 0.4× 108 0.9× 42 0.4× 22 0.5× 23 424
K Brune United States 8 79 0.4× 67 0.5× 81 0.7× 140 1.3× 37 0.8× 19 314
Shiori Uchiyama Japan 11 251 1.4× 157 1.2× 81 0.7× 206 2.0× 48 1.0× 24 544
Wenyu Shao China 11 106 0.6× 153 1.2× 35 0.3× 115 1.1× 21 0.4× 32 461
Zhe‐Ming Zhao China 11 130 0.7× 85 0.7× 89 0.8× 91 0.9× 22 0.5× 23 347
Yan Qin Tan Hong Kong 10 126 0.7× 25 0.2× 55 0.5× 56 0.5× 15 0.3× 21 278

Countries citing papers authored by Chih-Ming Su

Since Specialization
Citations

This map shows the geographic impact of Chih-Ming Su's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Chih-Ming Su with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Chih-Ming Su more than expected).

Fields of papers citing papers by Chih-Ming Su

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Chih-Ming Su. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Chih-Ming Su. The network helps show where Chih-Ming Su may publish in the future.

Co-authorship network of co-authors of Chih-Ming Su

This figure shows the co-authorship network connecting the top 25 collaborators of Chih-Ming Su. A scholar is included among the top collaborators of Chih-Ming Su based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Chih-Ming Su. Chih-Ming Su is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Wang, Wanyu, Hsin‐An Chen, Chih-Ming Su, et al.. (2025). FOXO3a/miR-4259-driven LDHA expression as a key mechanism of gemcitabine sensitivity in pancreatic ductal adenocarcinoma. Cancer & Metabolism. 13(1). 7–7. 1 indexed citations
2.
Hung, Chin‐Sheng, Chih-Ming Su, Limin Liao, et al.. (2024). Hypermethylation of the Gene Body in SRCIN1 Is Involved in Breast Cancer Cell Proliferation and Is a Potential Blood-Based Biomarker for Early Detection and a Poor Prognosis. Biomolecules. 14(5). 571–571. 1 indexed citations
3.
Loh, El‐Wui, et al.. (2023). Outcomes of Breast-Conserving Therapy in Patients With Inflammatory Breast Cancer: A Meta-Analysis. Journal of Surgical Research. 293. 458–467. 2 indexed citations
5.
6.
7.
Lin, Ruo-Kai, Chih-Ming Su, Le Thi Anh Thư, et al.. (2022). Hypermethylation of TMEM240 predicts poor hormone therapy response and disease progression in breast cancer. Molecular Medicine. 28(1). 67–67. 10 indexed citations
8.
Chen, Hsin‐An, Po‐Hsiang Liao, Yen‐Hao Su, et al.. (2022). Dicer-mediated miR-200b expression contributes to cell migratory/invasive abilities and cancer stem cells properties of breast cancer cells. Aging. 14(16). 6520–6536. 3 indexed citations
9.
Thư, Le Thi Anh, Chin‐Sheng Hung, Chih-Ming Su, et al.. (2022). Promoter hypomethylation and overexpression of TSTD1 mediate poor treatment response in breast cancer. Frontiers in Oncology. 12. 5 indexed citations
10.
11.
Huang, Tzu‐Wen, Chih-Ming Su, & Ka‐Wai Tam. (2020). Axillary Management in Women with Early Breast Cancer and Limited Sentinel Node Metastasis: A Systematic Review and Metaanalysis of Real-World Evidence in the Post-ACOSOG Z0011 Era. Annals of Surgical Oncology. 28(2). 920–929. 16 indexed citations
12.
Su, Chih-Ming, et al.. (2020). <p>Cryptanshinone Inhibits the Glycolysis and Inhibits Cell Migration Through PKM2/β-Catenin Axis in Breast Cancer</p>. OncoTargets and Therapy. Volume 13. 8629–8639. 26 indexed citations
13.
Chen, Lawrence R., Tsai‐Wei Huang, Yi‐Chun Kuan, et al.. (2017). Effect of acupuncture on aromatase inhibitor-induced arthralgia in patients with breast cancer: A meta-analysis of randomized controlled trials. The Breast. 33. 132–138. 39 indexed citations
14.
15.
Ma, Hon‐Ping, Chih-Ming Su, Yu‐Jia Chang, et al.. (2016). Alterations in histone deacetylase 8 lead to cell migration and poor prognosis in breast cancer. Life Sciences. 151. 7–14. 36 indexed citations
16.
Tam, Ka‐Wai, et al.. (2015). Effect of wound infiltration with ropivacaine or bupivacaine analgesia in breast cancer surgery: A meta-analysis of randomized controlled trials. International Journal of Surgery. 22. 79–85. 39 indexed citations
17.
Su, Chih-Ming, et al.. (2015). Sac ligation in inguinal hernia repair: A meta-analysis of randomized controlled trials. International Journal of Surgery. 19. 55–60. 10 indexed citations
18.
Su, Chih-Ming, Wei‐Hwa Lee, Alexander Wu, et al.. (2015). Pterostilbene inhibits triple-negative breast cancer metastasis via inducing microRNA-205 expression and negatively modulates epithelial-to-mesenchymal transition. The Journal of Nutritional Biochemistry. 26(6). 675–685. 62 indexed citations
19.
Su, Chih-Ming, Yen‐Hao Su, Ching‐Feng Chiu, et al.. (2014). Vascular Endothelial Growth Factor-C Upregulates Cortactin and Promotes Metastasis of Esophageal Squamous Cell Carcinoma. Annals of Surgical Oncology. 21(S4). 767–775. 25 indexed citations
20.
Su, Chih-Ming, et al.. (2007). Single-Centre Results of Treatment of Retroperitoneal and Mesenteric Cystic Lymphangiomas. Digestive Surgery. 24(3). 181–185. 23 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026